Associate Professor
University of Iowa
Rebecca Dodd, PhD, is an Associate Professor of Medicine at the University of Iowa and Co-Director of the Cancer Genes & Pathways Program at the Holden Comprehensive Cancer Center. Dr. Dodd completed her PhD and post-doctoral fellowship at Duke University, where she focused on sarcoma metastasis and MPNST biology.
Dr. Dodd's lab uses powerful in vivo model systems to address complex questions in cancer biology. Her research program uses CRISPR/Cas9 and Cre-loxP technology for translational oncology research. Over the past decade, her group has built new mouse models of MPNST to investigate events that are difficult to study in patient populations. These models include new approaches for in vivo modeling of cancer, including novel somatic CRISPR/Cas9-based somatic tumorigenesis tools. Other areas of interest include 1) epigenetically targeted therapies, 2) novel gene-editing tools, and 3) the tumor microenvironment and metastasis.
